Patent Yard Sign in
Australian application, no grantAustralia

Oxocoumarin and barbituric acid derivates their preparation and their use as ligand inhibitors of corticotropin-releasing factor CRF ND/or a CRF-binding protein complex

AU 1997031282 · Applicant: Neurocrine Biosciences Inc

AusPat record

Overview

Drawings and full text

Its specification, documents and status are on IP Australia's AusPat.

Open the AusPat record

Read the whole patent

Listed from its IP Australia record in Patent Yard's archive of Australian patents past their term. Its claims, description and drawings are in the AusPat record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 15, 1997. Even if it was granted, its term would have ended by May 15, 2018.
  • A pharmaceutical extension adds at most five years, so even that would have ended by May 15, 2023.
  • We check Australian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 15, 1997
GrantedNo grant recorded
Term ended byMay 15, 2018
Application numberAU 1997031282
Classification (IPC)A61K31/428 +2 more

Timeline

Timeline From IP Australia dates

1998200120042007201020132016Application filedMay 15, 1997Term ended byMay 15, 2018

Sources & verification

Everything on this page comes from the IP Australia record linked above. Data from IP Australia's IPGOD, licensed under CC BY 2.5 AU.